超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

日本Miraca Life Sciences  
miraca生命科學專家病理學服務提供的信息，他們需要做出重要的個體化治療決策的醫生。我們相信，更好的信息，可能導??致更有效的治療方法的選擇，并最終以更好的結果與癌癥和其他復雜疾病的患者。

miraca提供皮膚病，腸胃病學，血液學和泌尿系統等領域的專科病理解剖服務。我們還提供普通外科病理學服務。

我們的專家有良好記錄的準確診斷困難的??情況下 - 區分類似條件，準確地識別藥物和其他因素的影響。

我們的許多病理學家全國領導機構的教職員工，并積極參與研究的舉措。通過嚴格的質量保證，每天的會議，并與臨床合作伙伴的密切關系，我們不斷提高我們服務的每一天，成千上萬患者的診斷精度。

miraca生命科學是Miraca控股公司，日本最大的臨床診斷和實驗室測試服務供應商的子公司。卡里斯診斷，以前，該公司更名為2012年2月Miraca生命科學。
 

Miraca Life Sciences' expert pathology services provide physicians with the information they need to make important individualized treatment decisions. We believe that better information can lead to more effective treatment selection and ultimately to better outcomes for patients with cancer and other complex diseases.

Miraca provides subspecialty anatomic pathology services in the fields of dermatology, gastroenterology, hematology and urology. We also offer general surgery pathology services.

Our specialists have a proven track record of accurately diagnosing difficult cases — from distinguishing between similar conditions to accurately identifying the effects of medications and other factors.

Many of our pathologists are faculty members at leading institutions nationwide and actively participate in research initiatives. Through rigorous quality assurance, daily conferences, and close relationships with clinical partners, we continuously improve diagnostic precision for the thousands of patients we serve each day.

Miraca Life Sciences is a subsidiary of Miraca Holdings, Inc., Japan’s largest clinical diagnostics and laboratory testing service provider. The company, previously known as Caris Diagnostics, was renamed Miraca Life Sciences in February 2012.

About Miraca Life Sciences
Miraca Life Sciences specializes in the development and commercialization of the highest quality anatomic pathology services, primarily in the fields of dermatopathology, hematopathology, gastrointestinal pathology and urologic pathology. The company’s core team of more than 70 world-leading, academic-caliber specialists utilize state of the art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 3,000 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.

About Miraca Holdings
With group net sales of ￥165.7 billion (FYE 3/2010), Miraca Holdings, a Japan-based holding company in the healthcare sector listed on the Tokyo Stock Exchange, is engaged in the business consisting of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses, which are conducted by its subsidiaries and affiliates including Fujirebio Inc., a leading supplier of in vitro diagnostics in Japan, and SRL, Inc. ("SRL"), Japan's largest commercial laboratory. SRL offers comprehensive clinical laboratory testing services to medical institutes throughout the nation, ranging from general testing to esoteric testing, including gene-based tests.